SOLID BIOSCIENCES INC (SLDB)
US83422E2046 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to SLDB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.34. This target is 330.27% above the current price.
SLDB was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SLDB.
In the previous month the buy percentage consensus was at a similar level.
SLDB was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-08 | Truist Securities | Initiate | Buy |
| 2024-12-13 | Wedbush | Initiate | Outperform |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | JMP Securities | Initiate | Market Outperform |
| 2024-11-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-06-24 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-06-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-28 | William Blair | Initiate | Outperform |
| 2024-03-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-15 | Citigroup | Initiate | Buy |
| 2024-03-14 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-11-11 | Barclays | Maintains | Overweight |
| 2022-11-11 | Piper Sandler | Maintains | Neutral |
| 2022-11-10 | SVB Leerink | Maintains | Market Perform |
| 2022-10-17 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-09-30 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-08-12 | Chardan Capital | Maintains | Buy |
| 2022-05-19 | Piper Sandler | Maintains | Neutral |